Lorlatinib/lorlatinib tablets drug price reference in 2026

Lorlatinib/Lorlatinib (Lorlatinib) is a targeted therapy drug mainly used to treat non-small cell lung cancer (NSCLC) with positive ALK (anaplastic lymphoma kinase) gene rearrangement. As an innovative drug, lorlatinib has certain demand in the market, especially for the treatment of advanced or metastatic non-small cell lung cancer. There are significant differences in drug prices between different regions and different versions of drugs, and patients need to fully understand the price differences of drugs from different sources when choosing drugs.

In China, the original drug of lorlatinib is produced by Pfizer, and its trade name is lorlatinib tablets. The drug has been included in the Category B medical insurance reimbursement list, providing patients with certain financial support. Common specifications are 90 tablets of 25mg and 30 tablets of 100mg. According to current market information, the price of the original drug lorlatinib is approximately 20,000 yuan per box. This is still a significant expense for most patients, but for patients who qualify for medical insurance, medical insurance can reimburse most of the cost, thereby reducing the financial burden.

In Hong Kong, the price of the original drug of lorlatinib is relatively high. The price of 10mg*30 tablets is usually between 30,000 to 50,000 yuan. The main reason for the price difference may be related to factors such as market supply and demand, drug import taxes and circulation costs.

In addition to original drugs, generic drugs produced in many countries have also appeared on the market. The emergence of generic drugs has provided patients with more choices, especially for some patients with tight financial conditions. Taking the 100mg*30 tablets produced by a Lao pharmaceutical factory as an example, the price of generic drugs is about 1,000 yuan. Although the ingredients of these generic drugs are almost the same as those of the original drugs, patients still need to be cautious when choosing due to different drug quality standards and production supervision in different countries. The price of generic drugs is much lower than that of original drugs, but the guarantee of quality and efficacy is still a key factor that patients need to consider.

References：https://www.lorbrena.com/